Evidence map›Paper›PMID 26208702›Full record

ReviewInflammation research : official journal of the European Histamine Research Society ... [et al.]2015

Role of nitric oxide in immune responses against viruses: beyond microbicidal activity.

Elaine Uchima Uehara, Beatriz de Stefano Shida, Cyro Alves de Brito

Abstract readReview
PubMed Publisher
In one paragraph

Review in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Peptide-Based Approaches for Pain Relief and Healing in Wounds.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Nitric Oxide Signaling and Sensing in Age-Related Diseases.Antioxidants (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Article
  12. Innate Immune-Enhancing Effect ofJournal of microbiology and biotechnology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elaine Uchima UeharaImmunology Center, Adolfo Lutz Institute, Av. Dr. Arnaldo, 351, 10º andar, São Paulo, 01246-902, Brazil.
Beatriz de Stefano ShidaImmunology Center, Adolfo Lutz Institute, Av. Dr. Arnaldo, 351, 10º andar, São Paulo, 01246-902, Brazil.
Cyro Alves de BritoImmunology Center, Adolfo Lutz Institute, Av. Dr. Arnaldo, 351, 10º andar, São Paulo, 01246-902, Brazil. cbrito@usp.br.ORCID http://orcid.org/0000-0002-9934-6102
Universidade de São Paulo · BRInstituto Adolfo Lutz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNitric oxide (NO) is a free radical produced during L-arginine metabolism. In addition to its physiological activities in vascular and neuronal functions, its role in the immune system as a microbicide and tumor-killing mediator has been well described, as well as its release by activated macrophages. Furthermore, NO is produced by a variety of immune and non-immune cells and is involved in the regulation of several immune functions, such as T-cell polarization and suppression.

resultsViral infections generally promote NO production; however, according to its concentration, NO can trigger different effector mechanisms in immune responses. NO can activate the second messenger cyclic guanosine monophosphate (cGMP), can increase the cytoplasmic p53 tumor suppressor molecule, and can modify host and viral molecules by nitrosylation. Because of its microbicide function, NO has frequently been considered a protective mediator in viral infections; however, in some cases NO could be deleterious, potentiating inflammation or contributing to virus latency.

conclusionsThus, advances in the knowledge of the role of NO in immunomodulation and in the pathogenesis of viral diseases could contribute not only to the development of vaccines and therapeutic strategies but also to the use of its metabolites (nitrate/nitrite) and the enzyme responsible for its production (iNOS) as prognostic markers of some of these viral infections.

Indexed as

AnimalsHumansNitric OxideNitric Oxide Synthase Type IIPrognosisViral ProteinsVirus DiseasesNitric OxideNitric Oxide Synthase Type IIViral ProteinsImmune responseImmunomodulationNitric oxideVirus

Identifiers

PMID26208702
OpenAlexW2122204497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.